Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-114447
Filing Date
2015-03-31
Accepted
2015-03-31 17:28:13
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d857275d10k.htm 10-K 1186334
2 EX-10.32.1 d857275dex10321.htm EX-10.32.1 10524
3 EX-10.32.2 d857275dex10322.htm EX-10.32.2 10500
4 EX-10.33.1 d857275dex10331.htm EX-10.33.1 9719
5 EX-23.1 d857275dex231.htm EX-23.1 1720
6 EX-31.1 d857275dex311.htm EX-31.1 6379
7 EX-31.2 d857275dex312.htm EX-31.2 6193
8 EX-32.1 d857275dex321.htm EX-32.1 3805
  Complete submission text file 0001193125-15-114447.txt   6873216

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT bgmd-20141231.xml EX-101.INS 775264
10 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20141231.xsd EX-101.SCH 59861
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20141231_cal.xml EX-101.CAL 71073
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20141231_def.xml EX-101.DEF 358452
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20141231_lab.xml EX-101.LAB 503092
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20141231_pre.xml EX-101.PRE 422900
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

EIN.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33827 | Film No.: 15740535
SIC: 2835 In Vitro & In Vivo Diagnostic Substances